MedPath

AURO-LAMIVUDINE

AURO-LAMIVUDINE

Discontinued
DIN Number

02410567

Drug Class

Human

Market Date

Oct 16, 2013

Company
HC

auro pharma inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02410567
AIG Number0128157005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AF05 LAMIVUDINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:18.08.20
Health Canada Classification

ACTIVE INGREDIENTS (1)

LAMIVUDINEActive
Strength: 300 MG
Monograph: LAMIVUDINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.